Basic pharmacology of esmolol
References (29)
- et al.
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications
Am Heart J
(1979) - et al.
Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol
Lancet
(1984) Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy
Am Heart J
(1980)- et al.
Continuous monitoring of left ventricular performance with the computerized nuclear probe during laryngnoscopy and intubation before coronary artery bypass surgery
Am J Cardiol
(1982) - et al.
Propranolol and cardiac surgery
J Thorac Cardiovasc Surg
(1972) - et al.
Ultra-short acting beta-blockers: a proposal for the treatment of the critically ill patients
Life Sci
(1982) - et al.
Cardiovascular pharmacology of ASL-8052, an ultra-short acting beta-blocker
Eur J Pharmacol
(1983) Beta-blockers in coronary artery disease
Cardiovasc Rev
(1981)Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
N Engl J Med
(1981)A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
JAMA
(1982)
Reduction in infarct size, arrhythmias and chest pain by early intravenous beta-blockade in suspected acute myocardial infarction
Circulation
(1983)
Reduction of infarct size with the early use of timolol in acute myocardial infarction
N Engl J Med
(1984)
Effect of propranolol on myocardial-infarct size in a randomized blended multicenter trial
N Engl J Med
(1984)
A review of acute phase beta-blocker trials in patients with acute myocardial infarction
Circulation
(1983)
Cited by (0)
Copyright © 1985 Published by Elsevier Inc.